Revolutionary nicotine patch: New hope for long-covid patients!

Revolutionary nicotine patch: New hope for long-covid patients!

In March 2025, Dr. med. Marco Leitzke, senior physician at the Helios Klinik Leisnig, the results of a promising treatment method for long-covid patients. In cooperation with the clinic and polyclinic for nuclear medicine at the University Hospital Leipzig under the direction of Prof. Dr. Osama Sabri managed to identify the use of nicotine plasters as effective help for those affected. The results show that the symptoms of long-covid can be alleviated or even healed by using nicotine sustainably [helios-gesundheit.de] (https://www.helios-gesundheit.de/standorte-angete/kliniken/leipzig/news/2025/3000-long-covid-belze-informieren-sich-ueber-niktin therapy/).

The treatment successes are impressive. They range from immediate and significant pain relief to the gradual weakening of the symptoms in the course of the therapy. Since the beginning of Covid 19 pandemic, scientists have been investigating the causes and possible treatment approaches for long-covid that affects millions of people worldwide. The most common symptoms include chronic exhaustion, memory problems and shortness of breath. In a new study it was found that disturbed cholinergic neurotransmission is a possible cause of the symptoms, since SARS-COV-2 infections block the azetylcholine receptors, which affects essential body functions, such as longcovid-ambulanzen.de explained.

Effectiveness of the nicotine plaster

In the study mentioned in the journal * Bioelectronic Medicine *, the researchers found that nicotine can free the blocked receptors. The patients treated with nicotine plasters not only experienced a significant improvement in their symptoms, some even reported complete remissions. A survey of 231 people affected showed that 73.5 percent reported a significant improvement after the treatment. Ulrike Hundertmark, one of the participants, announced that she was able to return to her normal life after therapy. Dr. Leitzke emphasizes that transdermal nicotine has no addictive potential and is not carcinogenic, which makes the method additional attractive.

The treatment not only aimed at short -term relief, but also shows the potential for a lasting improvement in the quality of life of the patients. Nevertheless, it should be noted that further research is necessary to understand the long-term effects of nicotine patch therapy in detail, as longcovid-ambulanzen.de.

The current results of the studies offer the Long-Covid patients new perspectives and hope of effective therapy that could enable many of them to return to a symptom-free life. The development and implementation of new treatment methods is of central importance in order to counter the challenges of continuing COVID-19 pandemic.